HomeInsights52 Week High Stocks

Aurobindo Pharma Ltd 52 Week High

Aurobindo Pharma Ltd 52 Week High

stocks purchased

₹ 2.1 Cr

Volume transacted

stocks purchased

15.0 K

stocks traded

Last Updated time: 05 Nov 15:14 PM

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

YEARHIGH

1592.55

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week HIGH of Aurobindo Pharma Ltd is ₹ 1592 as of 04 Nov 24.

Company Fundamentals for Aurobindo Pharma Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241407.25
01 Nov 20241401.1
31 Oct 20241396
30 Oct 20241404.7
29 Oct 20241412.65
28 Oct 20241433.85
25 Oct 20241427.15
24 Oct 20241441.75
23 Oct 20241435.05
22 Oct 20241446.5

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma to table results

Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 9 Novembe...

Read more

02 Nov 202412:52

News

Aurobindo Pharma completes acquisition of balance 49% stake in GLS Pharma

Aurobindo Pharma has completed the acquisition of balance 49% stake in its subsidiary, GLS...

Read more

25 Oct 202419:30

News

Aurobindo Pharma Ltd spurts 1.19%, up for fifth straight session

Aurobindo Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs...

Read more

09 Oct 202413:00

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV

Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:19

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'

Aurogen South Africa (Aurogen), a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:21

News

Auro Pharma gets USFDA nod for urinary tract infections drug.

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Oct 202414:58

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Aurobindo Pharma Ltd

What is the significance of Aurobindo Pharma Ltd reaching its 52-week high?

Aurobindo Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Aurobindo Pharma Ltd 52-week high?

Investors monitor Aurobindo Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Aurobindo Pharma Ltd a good buy when it hits its 52-week high?

Whether Aurobindo Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Aurobindo Pharma Ltd fundamentals.

What should I consider before investing in Aurobindo Pharma Ltd at its 52-week high?

Before investing in Aurobindo Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Aurobindo Pharma Ltd stock price continue to rise after reaching its 52-week high?

Aurobindo Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*